Dr. Albert Gough has received funding under an SBIR entitled “Development and Evaluation of a high through IPS Hepatotoxicity Screening Platform”
More…
Dr. Albert Gough receives joint SBIR funding to develop a hepatotoxicity platform
Dr. Albert Gough has received funding under an SBIR entitled “Development and Evaluation of a high through IPS Hepatotoxicity Screening Platform”
More…